Home Page

Awareness Building

Amyloidosis Info

Amyloidosis Centers

TTR & Familial

Important Clinical Trials

Patient Registry

Upcoming Events


About Us

Contact Us


Treatment Centers

Awareness Items

AMY Blogs

Patient's Day

In Memoriam


Were you diagnosed with Cerebral Amyloid Angiopathy (CAA)?
Click Here

Amyloidosis Support Groups

We are a phone call or email away!
24/7 TOLL FREE HELP/HOT LINE: 866-404-7539
OR EMAIL: Info@amyloidosissupport.org

Jeffrey A. Zonder, MD
Associate Professor of Medicine
Wayne State University School of Medicine
Department of Internal Medicine
Division of Hematology/Oncology
Barbara Ann Karmanos Cancer Institute


Dr. Zonder has a lead role in Multiple Myeloma research at Karmanos Cancer Institute (http://www.karmanos.org/) , one of only 39 NCI Comprehensive Cancer Centers in the country. Dr. Zonder has had a specific interest in amyloidosis, multiple myeloma and closely related diseases since he was in Medical School at Wayne State University. He is a member of several professional societies including ASH, ASCO, International Amyloidois society and SWOG. Dr. Zonder's primary research interest is investigating new drug applications for malignant plasma cell disorders.

In addition to his role as the PI for 13 active myeloma trials and co-investigator for other 16 leukemia and lymphoma studies at the Karmanos Cancer Institute, Dr. Zonder was also the National Study Coordinator (PI) for the SWOG study S0232 - Dexamethasone +/- Lenalidomide for patients with newly diagnosed Multiple Myeloma, the results of which were published on a manuscript in Blood September 27th, 2010 (First Edition online)

Dr. Zonder was the national PI for a study for primary systemic (AL)-Amyloidosis evaluating the combination of melphalan, dexamethasone, and bortezomib. This study was coordinated at Karmanos by a highly motivated team of professional researchers. The most completed results of this study were presented at the International Amyloidosis symposium in Rome (April 2010)

Upcoming Event: Karmanos Myeloma and Amyloidosis Patient Day - free to all patients and their families regardless of where they currently receive their cancer therapy, this program will offer patient-friendly informational seminars addressing a variety of topics, good food, free massage, and information from local and national vendors, foundations, and support groups. Date: October 16th, 2010. If interested, please register at: https://www.karmanos.org/myelomaregistration. This is the second patient day symposium that Karmanos is organizing at the Palace of Auburn Hills. The first time, this event attracted about 250 participants.

Dr. Zonder CV (MS Word document) and Bio

Support Groups


WEBINARS (Virtual Meetings)

Arizona (Phoenix)

California (Los Angeles)

California (San Diego)




Florida (Jacksonville)

Florida (Miami)

Florida (Tampa)



Kansas City


Maryland (Baltimore/D.C.)

Maryland (Hagerstown)




New York City

New York (Rochester)

North Carolina

OSU/Cleveland Clinic



St. Louis

South Carolina

Texas (Dallas)

Texas (Houston)



Washington (Seattle)

Washington (Spokane)

Washington DC

We invite our pharmaceutical liaisons to our support group meetings to help in our goal of educating and empowering our patients. The donations and/or grant received from these companies are unconditional, and the ASG does not endorse any one of their products over any other types of amyloidosis treatment. These treatments are mentioned at our meetings, on our website, and other electronic format for educational purposes. We encourage you to consult your amyloidosis professional when choosing a treatment plan.

Order ASG Shirts Here (PDF Form)